FDA Investigator Laura Schankweiler
Laura Schankweiler has inspections in 1 countries as of 07 Sep 2023. Laura Schankweiler has collaborated with a combined 345 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
1
Last Inspection Date:
07 Sep 2023
Investigator Role:
FDA Investigation Participant
Redica ID:
Country:
United States of America
Co-Investigator(s):
Alia Legaux,
Amy W Yan Mai,
Burnell M Henry,
Dr. Gang Wang, PhD,
Evelyn Taha,
Gene D Arcy,
Gloria E Parra,
Gloria Parra,
Haydee B Romero,
Irina Gaberman,
Jacqueline Mdiaz Albertini,
Laura M Howard,
Leena Thomas,
Lisa Mathew,
LTJG Matthew R Palo,
Mercy O Quagraine,
Mohammad Heidaran, PhD,
Peter Abel,
Valerie Grecek Trinh,
Valerie J Grecek Trinh
Laura Schankweiler's Documents
Publish Date | Document Type | Title |
---|---|---|
May, 2001 | FDA 483 | New York Blood Center, Inc. - Form 483, 2001-05-21 |
May, 2001 | FDA 483 Response | New York Blood Center, Inc. - Form 483R, 2001-08-15 |
May, 2001 | EIR | New York Blood Center, Inc. - EIR, 2001-05-21 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more